We serve Chemical Name:3,4-dimethoxy-N-phenylbenzamide CAS:1522-67-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,4-dimethoxy-N-phenylbenzamide
CAS.NO:1522-67-4
Synonyms:(3,4-dimethoxyphenyl)-N-benzamide;3,4-Dimethoxy-benzoesaeure-anilid;3,4-Dimethoxy-benzanilid;3,4-dimethoxy-benzoic acid anilide;N-phenyl-3,4-dimethoxybenzamide;Veratrumsaeure-anilid
Molecular Formula:C15H15NO3
Molecular Weight:257.28400
HS Code:2924299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:47.56000
Exact Mass:257.10500
LogP:3.02910
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (3,4-dimethoxyphenyl)-N-benzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Veratrumsaeure-anilid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Dimethoxy-benzoesaeure-anilid Use and application,3,4-dimethoxy-benzoic acid anilide technical grade,usp/ep/jp grade.
Related News: ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 3,4-dimethoxy-N-phenylbenzamide manufacturer The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. 3,4-dimethoxy-N-phenylbenzamide supplier Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. 3,4-dimethoxy-N-phenylbenzamide vendor ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 3,4-dimethoxy-N-phenylbenzamide factory ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.��
